Related Experiment Video
Updated: Jan 24, 2026

Quantification of Plasmid-Mediated Antibiotic Resistance in an Experimental Evolution Approach
Published on: December 14, 2019
The rise and spread of mcr plasmid-mediated polymyxin resistance
Sue C Nang1, Jian Li1, Tony Velkov2
1a Department of Microbiology, Monash Biomedicine Discovery Institute , Monash University , Melbourne , Australia.
Abstract:
Polymyxins are important lipopeptide antibiotics that serve as the last-line defense against multidrug-resistant (MDR) Gram-negative bacterial infections. Worryingly, the clinical utility of polymyxins is currently facing a serious threat with the global dissemination of mcr, plasmid-mediated polymyxin resistance. The first plasmid-mediated polymyxin resistance gene, termed as mcr-1 was identified in China in November 2015. Following its discovery, isolates carrying mcr, mainly mcr-1 and less commonly mcr-2 to -7, have been reported across Asia, Africa, Europe, North America, South America and Oceania. This review covers the epidemiological, microbiological and genomics aspects of this emerging threat to global human health. The mcr has been identified in various species of Gram-negative bacteria including Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Salmonella enterica, Cronobacter sakazakii, Kluyvera ascorbata, Shigella sonnei, Citrobacter freundii, Citrobacter braakii, Raoultella ornithinolytica, Proteus mirabilis, Aeromonas, Moraxella and Enterobacter species from animal, meat, food product, environment and human sources. More alarmingly is the detection of mcr in extended-spectrum-β-lactamases- and carbapenemases-producing bacteria. The mcr can be carried by different plasmids, demonstrating the high diversity of mcr plasmid reservoirs. Our review analyses the current knowledge on the emergence of mcr-mediated polymyxin resistance.
Insights
The spread of plasmid-mediated polymyxin resistance (mcr) genes threatens last-line antibiotic defenses against Gram-negative bacteria. This review analyzes the epidemiology, microbiology, and genomics of this emerging global health threat.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Polymyxins are crucial last-line antibiotics for treating multidrug-resistant (MDR) Gram-negative bacterial infections.
- The emergence and global spread of plasmid-mediated polymyxin resistance (mcr) genes pose a significant threat to their clinical utility.
- The first mcr gene (mcr-1) was identified in 2015, with subsequent reports of various mcr genes (mcr-2 to -7) worldwide.
Purpose of the Study:
- To review the epidemiological, microbiological, and genomics aspects of mcr-mediated polymyxin resistance.
- To analyze the current knowledge on the emergence and dissemination of mcr genes.
- To highlight the implications of mcr genes for global human health.
Main Methods:
- Literature review encompassing epidemiological data.
- Microbiological characterization of mcr-carrying isolates.
- Genomic analysis of mcr genes and their plasmid reservoirs.
Main Results:
- mcr genes have been detected in numerous Gram-negative bacteria, including *Escherichia coli* and *Klebsiella pneumoniae*, across diverse sources (animals, food, environment, humans) and continents.
- mcr genes are found on various plasmids, indicating a diverse reservoir.
- Co-occurrence of mcr genes with genes for extended-spectrum beta-lactamases and carbapenemases is a major concern.
Conclusions:
- The global dissemination of mcr genes represents a critical threat to polymyxin efficacy.
- Understanding the epidemiology, microbiology, and genomics of mcr is essential for combating this resistance.
- Urgent strategies are needed to mitigate the impact of mcr-mediated resistance on public health.
Related Concept Videos
Spreading of Chromatin Modifications
Writers
The writer...
Rise of Liquid in a Capillary Tube
Plasmids
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...

